Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2015 Oct 2

PMID 26426635

Citations 25

Authors

Jun-Te Hsu

Chun-Kai Liao

Puo-Hsien Le

Tsung-Hsing Chen

Chun-Jung Lin

Jen-Shi Chen

Kun-Chun Chiang

Ta-Sen Yeh

Affiliations

Soon will be listed here.

Abstract

This study aimed to investigate the prognostic value of the preoperative neutrophil to lymphocyte ratio (NLR) in resectable gastric cancer (GC). This was a retrospective review of 1030 patients with resectable GC managed between 2005 and 2011. Patients were stratified into 2 groups, those with a preoperative NLR >3.44 and those with a preoperative NLR ≤ 3.44. Clinicopathological data affecting patient prognosis were collected prospectively and analyzed. The high NLR (> 3.44) group had a higher proportion of a platelet to lymphocyte ratio > 132, tumor size > 4.8 cm, T4 lesions, metastatic tumors, a ratio of metastatic to examined lymph nodes >0.18, positive resection margins, and presence of vascular or lymphatic invasion than the low NLR (≤ 3.44) group. Patients with a high preoperative NLR had significantly lower 3- and 5-year overall survival rates than those with a low preoperative NLR (55.1% vs 71.0% and 47.2% vs 64.1%, respectively; P < 0.001). Preoperative NLR was a prognostic factor for resectable GC in multivariate analysis. More aggressive tumor behavior was observed in patients with resectable GC with a high preoperative NLR than in those with a low preoperative NLR. High preoperative NLR was an independent unfavorable prognostic factor. Measurement of this ratio may serve as a clinically accessible and useful biomarker for patient outcomes.

Citing Articles

Inflammatory Ratios as Predictors for Tumor Invasiveness, Metastasis, Resectability and Early Postoperative Evolution in Gastric Cancer.

Nechita V, Al-Hajjar N, Mois E, Furcea L, Nechita M, Graur F Curr Oncol. 2022; 29(12):9242-9254.

PMID: 36547138 PMC: 9776857. DOI: 10.3390/curroncol29120724.

The Significance of Fibrinogen in Combination with the Neutrophil to Lymphocyte Ratio in Predicting the Prognosis of Patients with Gastric Cancer.

Li X, Zheng J, Yan M, Lu Y, Pan X Cancer Manag Res. 2022; 14:2313-2321.

PMID: 35958950 PMC: 9359806. DOI: 10.2147/CMAR.S374978.

Preoperative Neutrophil to Lymphocyte Ratio Predicts Complications After Esophageal Resection That can be Used as Inclusion Criteria for Enhanced Recovery After Surgery.

Shi B, Xu L, Gong C, Yang F, Han Y, Chen H Front Surg. 2022; 9:897716.

PMID: 35910480 PMC: 9326077. DOI: 10.3389/fsurg.2022.897716.

Association between neutrophil-lymphocyte ratio and lymph node metastasis in gastric cancer: A meta-analysis.

Kotecha K, Singla A, Townend P, Merrett N Medicine (Baltimore). 2022; 101(25):e29300.

PMID: 35758361 PMC: 9276313. DOI: 10.1097/MD.0000000000029300.

Systematic Review of Prognostic Role of Blood Cell Ratios in Patients with Gastric Cancer Undergoing Surgery.

Schiefer S, Wirsik N, Kalkum E, Seide S, Nienhuser H, Muller B Diagnostics (Basel). 2022; 12(3).

PMID: 35328146 PMC: 8947199. DOI: 10.3390/diagnostics12030593.

References

Gao F, Li X, Geng M, Ye X, Liu H, Liu Y . Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma. Medicine (Baltimore). 2015; 94(11):e639. PMC: 4602488. DOI: 10.1097/MD.0000000000000639. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Li M, Liu X, Zhang X, Zhang J, Wang W, Zhu Y . Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2013; 134(10):2403-13. DOI: 10.1002/ijc.28536. View

Zhang X, Zhang W, Feng L . Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis. PLoS One. 2014; 9(11):e111906. PMC: 4234250. DOI: 10.1371/journal.pone.0111906. View

Jeong J, Lim S, Yun J, Rhee G, Lim J, Cho J . Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer. Oncology. 2012; 83(5):292-9. DOI: 10.1159/000342376. View

Sugiura T, Uesaka K, Kanemoto H, Mizuno T, Okamura Y . Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma. Ann Surg Oncol. 2013; 20(13):4330-7. DOI: 10.1245/s10434-013-3227-8. View

Ishizuka M, Oyama Y, Abe A, Kubota K . Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer. J Surg Oncol. 2014; 110(8):935-41. DOI: 10.1002/jso.23753. View

Graziosi L, Marino E, De Angelis V, Rebonato A, Cavazzoni E, Donini A . Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer. Am J Surg. 2014; 209(2):333-7. DOI: 10.1016/j.amjsurg.2014.06.014. View

Cho I, Park J, Park C, Jo J, Lee H, Kim S . Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. 2014; 17(4):703-10. DOI: 10.1007/s10120-013-0330-2. View

10.

Fang H, DeClerck Y . Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res. 2013; 73(16):4965-77. PMC: 3815577. DOI: 10.1158/0008-5472.CAN-13-0661. View

11.

Xiao L, Zhao S, Zhao E, Zheng X, Gou W, Takano Y . Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett. 2013; 6(5):1277-1284. PMC: 3813574. DOI: 10.3892/ol.2013.1532. View

12.

Wang F, Chang Y, Chen T, Hsu J, Kuo C, Lin C . Prognostic significance of splenectomy for patients with gastric adenocarcinoma undergoing total gastrectomy: a retrospective cohort study. Int J Surg. 2014; 12(6):557-65. DOI: 10.1016/j.ijsu.2014.04.006. View

13.

Dumitru C, Lang S, Brandau S . Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin Cancer Biol. 2013; 23(3):141-8. DOI: 10.1016/j.semcancer.2013.02.005. View

14.

Cheng C, Tsai C, Hsu J, Vinayak R, Liu K, Yeh C . Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth?. Ann Surg Oncol. 2011; 18(6):1606-14. DOI: 10.1245/s10434-010-1534-x. View

15.

Namikawa T, Fukudome I, Ogawa M, Munekage E, Munekage M, Shiga M . Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1). Eur J Surg Oncol. 2015; 41(6):795-800. DOI: 10.1016/j.ejso.2015.02.012. View

16.

Chen J, Hong D, Zhai Y, Shen P . Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer. World J Surg Oncol. 2015; 13:122. PMC: 4379945. DOI: 10.1186/s12957-015-0530-9. View

17.

Wagner A, Grothe W, Haerting J, Kleber G, Grothey A, Fleig W . Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006; 24(18):2903-9. DOI: 10.1200/JCO.2005.05.0245. View

18.

Jung M, Park Y, Jeong O, Seon J, Ryu S, Kim D . Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol. 2011; 104(5):504-10. DOI: 10.1002/jso.21986. View

19.

Shau H, Kim A . Suppression of lymphokine-activated killer induction by neutrophils. J Immunol. 1988; 141(12):4395-402. View

20.

Wang Q, Zhu Y, Zhang H, Xiao J . Altered MiRNA expression in gastric cancer: a systematic review and meta-analysis. Cell Physiol Biochem. 2015; 35(3):933-44. DOI: 10.1159/000369750. View